![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
USOTC:LEGX | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
As discussed previously, the company moved to a single master distributor relationship at the end of December 2010, which resulted in a significant short term slowdown in shipments as new marketing strategies were implemented. These new strategies included redesign of packaging, point of purchase displays, and shipping cartons. The new lineup of product has been well received at industry shows over the past month and the company anticipates continued growth in all product categories.
"Probably the biggest surprise about our new distribution partner, Kretek International, has been their ability to promote our full line of products, not just Libigrow. We are experiencing strong demand for our female line of products and anticipate announcing new items that will complement our already existing female brands," stated Alex Hbaiu, CEO. "For the first time, we are beginning to see retailers carrying our entire line of male and female products. This is clearly providing the basis for our increases in sales online, especially product offerings that include both male and female pills together."
In the coming months, the company plans to begin its comprehensive national marketing campaign to help create brand awareness and drive retail and online sales. "Our strategy appears to be working according to plan, unfortunately we suffered a longer than anticipated slowdown due to the changeover to Kretek, Int. however, sales are increasing again and we appear to be back on track," states Mr. Hbaiu. "We are working hard to reach our growth targets for 2011."
About True 2 Beauty, Inc.
True 2 Beauty, Inc. is a leading distributor of male and female sexual potency pills and liquid products in the United States. The True 2 Beauty, Inc. line of current products includes Libigrow, Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink. More information on the Company and its line of products can be found at www.true2beautyinc.com and www.libigrow.com.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, among others, all assumptions, expectations, predictions, intentions or beliefs about future events. You are cautioned that any such forward-looking statements are not guarantees of future performance and that a number of risks and uncertainties could cause actual results of the Company to differ materially from those anticipated, expressed or implied in the forward-looking statements. The words "believe," "expect," "anticipate," "project," "targets," "optimistic," "intend," "aim," "will" or similar expressions are intended to identify forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Risks and uncertainties that could cause actual results to differ materially from those anticipated include risks related to new and existing products, product defects and any related product recall; any projections of sales, earnings, revenue, margins or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements. The Company assumes no obligation and does not intend to update any forward-looking statements, except as required by law.
For further information, please contact: Investors Relations Contact: New York World Asset Management (702) 436-4562 Media Relations: Zara Hbaiu zara@libigrow.com 1-888-942-5350
1 Year Chart |
1 Month Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions